Search

Mark Rosenbaum

Examiner (ID: 3538, Phone: (571)272-4523 , Office: P/3725 )

Most Active Art Unit
3725
Art Unit(s)
3201, 3202, 3103, 3206, 3725, 3203, 3209, 3204, 2899, 3502, 3505
Total Applications
4526
Issued Applications
3830
Pending Applications
109
Abandoned Applications
597

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18058410 [patent_doc_number] => 20220389496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => METHODS AND CONTROL COMPOSITIONS FOR A QUANTITATIVE POLYMERASE CHAIN REACTION [patent_app_type] => utility [patent_app_number] => 17/884187 [patent_app_country] => US [patent_app_date] => 2022-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884187 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/884187
Methods and control compositions for a quantitative polymerase chain reaction Aug 8, 2022 Issued
Array ( [id] => 18056510 [patent_doc_number] => 20220387596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => BIODEGRADABLE HYDROGEL AND METHODS FOR USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/816456 [patent_app_country] => US [patent_app_date] => 2022-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816456 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/816456
BIODEGRADABLE HYDROGEL AND METHODS FOR USE THEREOF Jul 31, 2022 Abandoned
Array ( [id] => 18057963 [patent_doc_number] => 20220389049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/815725 [patent_app_country] => US [patent_app_date] => 2022-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18491 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815725 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/815725
REVERSIBLE TERMINATORS FOR DNA SEQUENCING AND METHODS OF USING THE SAME Jul 27, 2022 Pending
Array ( [id] => 19490522 [patent_doc_number] => 12109206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-08 [patent_title] => Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders [patent_app_type] => utility [patent_app_number] => 17/872575 [patent_app_country] => US [patent_app_date] => 2022-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7397 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872575 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/872575
Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders Jul 24, 2022 Issued
Array ( [id] => 18226788 [patent_doc_number] => 20230065782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES [patent_app_type] => utility [patent_app_number] => 17/812657 [patent_app_country] => US [patent_app_date] => 2022-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17812657 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/812657
TARGETED AND LOCALIZED IN VIVO DELIVERY OF OLIGONUCLEOTIDES Jul 13, 2022 Pending
Array ( [id] => 19418797 [patent_doc_number] => 20240294920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => MODULATION OF NOX4 EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/569084 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -49 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569084 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569084
MODULATION OF NOX4 EXPRESSION Jun 29, 2022 Pending
Array ( [id] => 19896912 [patent_doc_number] => 12274808 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-15 [patent_title] => Collagen-based therapeutic delivery systems [patent_app_type] => utility [patent_app_number] => 17/854139 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10998 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17854139 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/854139
Collagen-based therapeutic delivery systems Jun 29, 2022 Issued
Array ( [id] => 19188155 [patent_doc_number] => 20240167068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => METHOD FOR RNA MANUFACTURING [patent_app_type] => utility [patent_app_number] => 18/569372 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569372 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569372
METHOD FOR RNA MANUFACTURING Jun 29, 2022 Pending
Array ( [id] => 19432928 [patent_doc_number] => 20240301426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/575157 [patent_app_country] => US [patent_app_date] => 2022-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80718 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -118 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18575157 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/575157
LEUCINE-RICH REPEAT KINASE 2 (LRRK2) IRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF Jun 28, 2022 Pending
Array ( [id] => 17958569 [patent_doc_number] => 20220339149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => PALONOSETRON FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/851017 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11830 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851017 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/851017
PALONOSETRON FORMULATIONS AND USES THEREOF Jun 26, 2022 Abandoned
Array ( [id] => 18364655 [patent_doc_number] => 20230146246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors [patent_app_type] => utility [patent_app_number] => 17/844037 [patent_app_country] => US [patent_app_date] => 2022-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844037
Method of Modulating the Number and the Distribution of Tumor-Infiltrating Leukocytes in Tumors Jun 18, 2022 Pending
Array ( [id] => 19402289 [patent_doc_number] => 20240285800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => Retinal Disorders [patent_app_type] => utility [patent_app_number] => 18/570701 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21119 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18570701 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/570701
Retinal Disorders Jun 16, 2022 Pending
Array ( [id] => 19404008 [patent_doc_number] => 20240287519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS [patent_app_type] => utility [patent_app_number] => 18/569113 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18569113 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/569113
TREATMENT OF DKK2 RELATED DISEASES AND DISORDERS Jun 16, 2022 Pending
Array ( [id] => 17911198 [patent_doc_number] => 20220313593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Topical preparations comprising polyalkoxylated polyols polyester [patent_app_type] => utility [patent_app_number] => 17/838503 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6434 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838503 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/838503
Topical preparations comprising polyalkoxylated polyols polyester Jun 12, 2022 Abandoned
Array ( [id] => 17911197 [patent_doc_number] => 20220313592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => Liquid Thickener Composition Comprising Polyalkoxylated [patent_app_type] => utility [patent_app_number] => 17/838499 [patent_app_country] => US [patent_app_date] => 2022-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 330 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838499 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/838499
Liquid Thickener Composition Comprising Polyalkoxylated Jun 12, 2022 Abandoned
Array ( [id] => 18178692 [patent_doc_number] => 20230039421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => RESIDENCE STRUCTURES AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 17/836972 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34517 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836972 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836972
RESIDENCE STRUCTURES AND RELATED METHODS Jun 8, 2022 Pending
Array ( [id] => 19777384 [patent_doc_number] => 12226404 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Methods for making compositions for pulmonary administration [patent_app_type] => utility [patent_app_number] => 17/836067 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 15 [patent_no_of_words] => 13430 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836067 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/836067
Methods for making compositions for pulmonary administration Jun 8, 2022 Issued
Array ( [id] => 18716491 [patent_doc_number] => 11793813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Pemetrexed formulations [patent_app_type] => utility [patent_app_number] => 17/835236 [patent_app_country] => US [patent_app_date] => 2022-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 9355 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17835236 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/835236
Pemetrexed formulations Jun 7, 2022 Issued
Array ( [id] => 19497921 [patent_doc_number] => 20240336939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => CRISPR INDUCED DISRUPTION OF MOGS GENE [patent_app_type] => utility [patent_app_number] => 18/566446 [patent_app_country] => US [patent_app_date] => 2022-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18529 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/566446
CRISPR INDUCED DISRUPTION OF MOGS GENE Jun 1, 2022 Pending
Array ( [id] => 20179739 [patent_doc_number] => 20250263697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS [patent_app_type] => utility [patent_app_number] => 18/565689 [patent_app_country] => US [patent_app_date] => 2022-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13903 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565689 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/565689
COMPOSITIONS AND METHODS OF MODULATING RNA AND PROTEIN INTERACTIONS May 31, 2022 Pending
Menu